Literature DB >> 10839294

Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss.

M Hoshi1, N Otagiri, H O Shiwaku, S Asakawa, N Shimizu, Y Kaneko, R Ohi, Y Hayashi, A Horii.   

Abstract

Neuroblastoma (NB) is a well-known malignant disease in infants, but its molecular mechanisms have not yet been fully elucidated. To investigate the genetic contribution of abnormalities on the long arm of chromosome 14 (14q) in NB, we analysed loss of heterozygosity (LOH) in 54 primary NB samples using 12 microsatellite markers on 14q32. Seventeen (31%) of 54 tumours showed LOH at one or more of the markers analysed, and the smallest common region of allelic loss was identified between D14S62 and D14S987. This region was estimated to be 1-cM long from the linkage map. Fluorescence in situ hybridization also confirmed the loss. There was no statistical correlation between LOH and any clinicopathologic features, including age, stage, amplification of MYCN and ploidy. We further constructed a contig spanning the lost region using bacterial artificial chromosome and estimated this region to be approximately 1.1-Mb by pulsed-field gel electrophoresis. Our results will contribute to cloning and characterizing the putative tumour-associated gene(s) in 14q32 in NB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839294      PMCID: PMC2363232          DOI: 10.1054/bjoc.2000.1108

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

1.  Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.

Authors:  H Shizuya; B Birren; U J Kim; V Mancino; T Slepak; Y Tachiiri; M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.

Authors:  H Takayama; T Suzuki; H Mugishima; T Fujisawa; M Ookuni; M Schwab; M Gehring; Y Nakamura; T Sugimura; M Terada
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

3.  Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer.

Authors:  S Nagase; H Yamakawa; S Sato; A Yajima; A Horii
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

4.  Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.

Authors:  C A Bandera; H Takahashi; K Behbakht; P C Liu; V A LiVolsi; I Benjamin; M A Morgan; S A King; S C Rubin; J Boyd
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

5.  Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma.

Authors:  M Theobald; H Christiansen; A Schmidt; B Melekian; N Wolkewitz; N M Christiansen; C Brinkschmidt; F Berthold; F Lampert
Journal:  Genes Chromosomes Cancer       Date:  1999-09       Impact factor: 5.006

6.  Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.

Authors:  C T Fong; P S White; K Peterson; C Sapienza; W K Cavenee; S E Kern; B Vogelstein; A B Cantor; A T Look; G M Brodeur
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

7.  Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.

Authors:  N Bown; S Cotterill; M Lastowska; S O'Neill; A D Pearson; D Plantaz; M Meddeb; G Danglot; C Brinkschmidt; H Christiansen; G Laureys; F Speleman; J Nicholson; A Bernheim; D R Betts; J Vandesompele; N Van Roy
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

8.  Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.

Authors:  J Young; B Leggett; M Ward; L Thomas; R Buttenshaw; J Searle; G Chenevix-Trench
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

9.  Neuroblastoma. Effect of genetic factors on prognosis and treatment.

Authors:  G M Brodeur; C Azar; M Brother; J Hiemstra; B Kaufman; H Marshall; J Moley; A Nakagawara; R Saylors; N Scavarda
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

10.  Neuroblastoma consensus deletion maps to 1p36.1-2.

Authors:  A Weith; T Martinsson; C Cziepluch; S Brüderlein; L C Amler; F Berthold; M Schwab
Journal:  Genes Chromosomes Cancer       Date:  1989-11       Impact factor: 5.006

View more
  10 in total

1.  Comparative genomic hybridization and mutation analyses of sporadic schwannomas.

Authors:  Takayuki Ikeda; Sho Hashimoto; Shinichi Fukushige; Hiroaki Ohmori; Akira Horii
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

2.  Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma.

Authors:  Arthur Kwok Leung Cheung; Hong Lok Lung; Josephine Mun Yee Ko; Yue Cheng; Eric J Stanbridge; Eugene R Zabarovsky; John M Nicholls; Daniel Chua; Sai Wah Tsao; Xin-Yuan Guan; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

3.  Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis.

Authors:  Arthur Kwok Leung Cheung; Josephine M Y Ko; Hong Lok Lung; Kwok Wah Chan; Eric J Stanbridge; Eugene Zabarovsky; Takashi Tokino; Lisa Kashima; Toshiharu Suzuki; Dora Lai-Wan Kwong; Daniel Chua; Sai Wah Tsao; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-03       Impact factor: 11.205

Review 4.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

5.  miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

Authors:  Holly Holliday; Jessica Yang; Eoin Dodson; Iva Nikolic; Alvin Kamili; Madeleine Wheatley; Niantao Deng; Sarah Alexandrou; Thomas P Davis; Maria Kavallaris; C Elizabeth Caldon; Joshua McCarroll; Katleen De Preter; Pieter Mestdagh; Glenn M Marshall; Kaylene J Simpson; Jamie Fletcher; Alexander Swarbrick
Journal:  Mol Ther       Date:  2022-01-05       Impact factor: 11.454

6.  Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas.

Authors:  Davut Pehlivan; Esra Gunduz; Mehmet Gunduz; Hitoshi Nagatsuka; Levent Bekir Beder; Beyhan Cengiz; Rosario S Rivera; Kunihiro Fukushima; Sukru Palanduz; Sukru Ozturk; Noboru Yamanaka; Kenji Shimizu
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-03       Impact factor: 4.553

7.  Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Authors:  Liron Zehavi; Roi Avraham; Aviv Barzilai; Dalia Bar-Ilan; Roy Navon; Yechezkel Sidi; Dror Avni; Raya Leibowitz-Amit
Journal:  Mol Cancer       Date:  2012-07-02       Impact factor: 27.401

8.  Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.

Authors:  Katleen De Preter; Jo Vandesompele; Pierre Heimann; Nurten Yigit; Siv Beckman; Alexander Schramm; Angelika Eggert; Raymond L Stallings; Yves Benoit; Marleen Renard; Anne De Paepe; Geneviève Laureys; Sven Påhlman; Frank Speleman
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

9.  Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis.

Authors:  M E Luttikhuis; J E Powell; S A Rees; T Genus; S Chughtai; P Ramani; J R Mann; C M McConville
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

10.  miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.

Authors:  Xuan Xiang; Hong Mei; Xiang Zhao; Jiarui Pu; Dan Li; Hongxia Qu; Wanju Jiao; Jihe Zhao; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Oncotarget       Date:  2015-09-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.